Respiri Limited ( (AU:RSH) ) just unveiled an update.
Respiri Limited has announced a proposed issue of 100 million ordinary fully paid securities, scheduled for March 10, 2025. This move is part of a placement or other type of issue aimed at raising capital, which could enhance the company’s financial position and support its strategic initiatives in the healthcare market. The issuance of these securities will be subject to ASX regulations, and the company plans to apply for their quotation on the ASX.
More about Respiri Limited
Respiri Limited operates in the healthcare industry, focusing on the development and commercialization of innovative respiratory health products. The company’s primary product is a digital wheeze monitoring device designed to assist individuals with asthma and other respiratory conditions, aiming to improve patient outcomes and reduce healthcare costs.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $44.76M
Find detailed analytics on RSH stock on TipRanks’ Stock Analysis page.